Brady Corporation (BRC)

Regulus Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Regulus Therapeutics.

Price Target: $0.00 (0.00%)

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for Regulus Therapeutics.

Recommendation Trends

Rating	Aug '23	Sep '23	Oct '23	Nov '23	Dec '23	Jan '24
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
George Staphos B of A Securities	B of A Securities	Sell → Strong Buy Upgrades $51 → $65	Sell → Strong Buy	Upgrades	$51 → $65	-7.76%	Jan 2, 2024
Michael Mcginn Wells Fargo	Wells Fargo	Buy → Hold Downgrades $52	Buy → Hold	Downgrades	$52	-26.21%	Feb 18, 2022
Michael Mcginn Wells Fargo	Wells Fargo	Buy Maintains $70 → $60	Buy	Maintains	$70 → $60	-14.86%	Jan 10, 2022
Michael Mcginn Wells Fargo	Wells Fargo	Sell → Buy Upgrades $70	Sell → Buy	Upgrades	$70	-0.67%	Jun 8, 2021
George Staphos B of A Securities	B of A Securities	Sell Maintains $45 → $44	Sell	Maintains	$45 → $44	-37.56%	Jun 4, 2020

More Analyst Ratings

Financial Forecast

Revenue This Year

1.52B

Increased by 13.02%

from 1.34B

Revenue Next Year

1.57B

Increased by 3.76%

from 1.52B

EPS This Year

4.62

Increased by 13.94%

from 4.05

EPS Next Year

4.80

Increased by 4.05%

from 4.62

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jul 31, 2020	Jul 31, 2021	Jul 31, 2022	Jul 31, 2023	Jul 31, 2024	Jul 31, 2025	Jul 31, 2026	Jul 31, 2027
Revenue	1.08B	1.14B	1.30B	1.33B	1.34B	1.52B	1.57B	1.64B
Revenue Growth	-6.84%	5.86%	13.75%	2.29%	0.72%	13.02%	3.76%	4.01%
EPS	2.10	2.46	2.89	3.49	4.05	4.62	4.80	5.24
EPS Growth	-14.34%	17.34%	17.47%	20.87%	16.05%	13.94%	4.05%	9.04%
Forward PE	-	-	-	-	-	15.27	14.67	13.46
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.6B	1.6B	1.7B
Avg	1.5B	1.6B	1.6B
Low	1.5B	1.5B	1.6B

Revenue Growth

Revenue Growth	2025	2026	2027
High	17.5%	8.8%	9.3%
Avg	13.0%	3.8%	4.0%
Low	9.7%	-0.1%	-0.2%

EPS Forecast

EPS	2025	2026	2027
High	4.81	5.30	5.83
Avg	4.62	4.80	5.24
Low	4.47	4.37	4.72

EPS Growth

EPS Growth	2025	2026	2027
High	18.7%	14.9%	21.3%
Avg	13.9%	4.0%	9.0%
Low	10.3%	-5.3%	-1.6%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.